Transaction · 0001022079-25-000074

PREVOZNIK MICHAEL E

PREVOZNIK MICHAEL E, SVP, GC, reported an open-market or private sale at QUEST DIAGNOSTICS INC involving 528.000000 shares for an estimated $91138.08. Reported holdings after the transaction were 39031.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP, GC
DGXQUEST DIAGNOSTICS INC
Filing timeFeb 28
Trade dateFeb 27, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

DGX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
DGX since 2025-02-28Filed 553 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001022079-25-000074
Common Stock
Transaction date
Feb 27, 2025
Filed Feb 28, 2025, 09:38 PM · 1d delay
Shares
528 sh
$17.2k per share
Estimated value
-$9.11M
Computed from shares × price
Holdings after
39.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP & General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

  2. F2

    This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

  3. F3

    These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obta…

Original filing · 0001022079-25-000074
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

DGX